Company: LRHC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032211
Chunk: 1230

Company: La Rosa Holdings Corp.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 3
Chunk 1230
---
 quarter of fiscal
year 2022 along with interest expense associated with the existing debt issuances in 2022, partially offset by a decrease in the
revaluation of the derivative liabilities and the IRS employee retention credit received for prior tax years, net of legal costs to
obtain the credit.

Liquidity and Capital Resources

On December 31, 2024 and 2023
we had cash of $1.4 million and $0.96 million, respectively, on hand.

In February 2024, we entered
into securities purchase agreement with an accredited investor for the issuance of a 13% senior secured promissory note with a principal
amount of $1,052,632 and a purchase price of $1,000,000 after an original issue discount of $52,632. The note was convertible into shares
of our Common Stock at the option of the lender. In addition, on April 1, 2024, we entered into securities purchase agreement with the
same accredited investor for the issuance of a 13% senior secured promissory note with a principal amount of $1,316,000 and a purchase
price of $1,250,200 after an original issue discount of $65,800. The note was convertible into shares of our Common Stock at the option
of the lender. The two promissory notes began amortizing five months after the date of each loan, with full maturity occurring twelve
months after the date of each loan.

In May 2024, we entered into a standard merchant cash advance agreement
with Cedar Advance LLC (“Cedar”) where we sold in the aggregate $761,250 in future receipts of the Company for $500,000. Until
the purchase price has been repaid, the Company agreed to pay Cedar $23,000 per week.

In July 2024, we received
$444,600 in net proceeds, excluding debt issuance costs of approximately $25,000, through our private sale of a 13% OID senior secured
promissory note in the principal amount of $468,000 for a purchase price of $444,600 to the same accredited investor in our February 2024
and April 2024 private placements.

In August 2024, we received $725,000 in net proceeds, excluding equity
issuance costs of approximately $25,000, by issuing 761,689 shares of Common stock and a pre-funded warrant to purchase 509,498 shares